You are here



The National Institute of Nursing Research (NINR) supports research focused on biological and behavioral aspects of critical health problems that confront the Nation. Emphasis is on seeking ways to reduce the burden of illness and disability by understanding and easing the effects of acute and chronic illness, improving health-related quality of life by preventing or delaying the onset of disease or slowing its progression, establishing better approaches to promote health and prevent disease, and improving clinical environments by testing interventions that influence patient health outcomes and reduce costs and demand for care. For additional information about areas of interest to the NINR, please visit our home page at Research and Development of Technologies for Health Promotion and Alleviation, Adaptation to, or Management of Symptoms A. Technologies to be used in the hospital, long-term care, hospice, assisted living facility, or home setting that improve symptom evaluation in persons with chronic conditions. Conditions of interest include congestive heart failure, cystic fibrosis, organ failure, cognitive impairment, renal disease, asthma, diabetes, or mobility impairments. B. Devices that improve the acceptance and use of assistive and monitoring devices, e.g., child peak flow measurement in the home and at school; nightly use of continuous positive airway pressure (CPAP). C. Devices to diagnose and screen for COPD early in the course of the disease, particularly targeting young adults. D. Technologies to assist in adolescent health promotion and prevention activities such as smoking cessation devices or obesity prevention technologies. E. Devices to assist in providing palliative care for patients with life threatening illnesses through the disease trajectory whether in active treatment or at the end of life. F. Technologies to assist individuals in reducing environmental exposures, i.e., chemical and viral agents, and indoor/outdoor allergens. G. Devices to facilitate resource sharing such as: technologies that will enable valid and reliable measurement tools/instruments to be readily available and shared by research scientist focused on similar issues in a variety of populations. H. Adaptation of existing or development of new technologies that will link under-represented populations with available resources to sustain healthy life styles and eliminate health disparities. Research and Development of Technologies to Enhance Self Care and Clinical Care A. Technologies to assist patients to adhere to chronic regimens such as reminding children to take steroid inhalers during the day for asthma; alerting obese adults when high calorie and fat content foods are about to be eaten; adhering to medication regimens; and prompting sedentary adults to exercise. B. Devices that improve delivery of care to persons who have restricted or impaired movement due to (1) conditions of neurological disease or injury, peripheral vascular disease, rheumatoid disease, or intractable pain, (2) life sustaining equipment, such as dialysis machines or left ventricular assist devices, or (3) orthopedic fixation devices. C. Devices to enable providers and or research scientists to monitor successful adherence to complex medication regimens (e.g., Highly Active Anti-Retroviral treatment). D. Technologies that monitor short and long term self-care behavior changes. E. Biological and behavioral monitoring devices for patients in at-risk and underserved populations in rural and frontier areas that will enable access to clinical care. F. Telehealth technologies to improve patient outcomes through increasing quality, type, and speed of health information sharing, e.g., assessing traumatic injury severity at remote sites and transmitting this information to acute care settings for assessment and evaluation; communicating signs and symptoms of clients at home to health care providers in distant locations; tailoring care for diverse patients in a wide variety of settings, and promoting community interventions to eliminate health disparities. G. Technologies to treat chronic wounds that fail to heal, specifically decubitus ulcers, venous stasis ulcers, and diabetic ulcers. H. Technologies to be used in the hospital or home care setting to monitor or assess preterm, low-birth weight or other high-risk infants. I. Technologies to assist informal caregivers in providing care or assistance to family members in the home. J. Noninvasive devices to assess exposure to chemical and viral agents for children and adults and transmit this information to health care personnel for assessment and evaluation. K. Technologies to disseminate research information (i.e., biobehavioral responses, communication of risk, bioethics) to nurses practicing in emergency settings and in the community. Other Research Topic(s) Within the Mission of the Institute For additional information on research topics, contact: Dr. Paul Cotton Program Director National Institute of Nursing Research 301-402-6423, Fax: 301-480-8260 Email: For administrative and business management questions, contact: Mr. Brian Albertini Chief, Grants and Contracts Management National Institute of Nursing Research Office of Grants and Contracts Management 6701 Democracy Boulevard, Room 710 One Democracy Plaza, MSC 4870 Bethesda, MD 20892-4870 (Courier delivery: Bethesda, MD 20817) 301-594-6869, Fax: 301-402-4502 Email:
US Flag An Official Website of the United States Government